Therapeutic insights into the treatment of Metabolic disorders: Argonaute-2 increases insulin sensitivity, restores mucosal immunity and decreases endotoxaemia via up regulation of Interleukin-22 (IL-22), 18/October/2014, 22.45

Life-extention therapy for Males: NRF2 increases male longevity via up regulation of its target gene, 18/October/2014, 22.34
October 18, 2014
Physiological and Pathological mechanisms that control glycolysis: Pro-inflammatory cytokine Resistin inhibits glycolysis and cancer progression via down regulation of PDK1, 19/October/2014, 6.28 am
October 19, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Therapeutic insights into the treatment of Metabolic disorders: Argonaute-2 increases insulin sensitivity, restores mucosal immunity and decreases endotoxaemia via up regulation of Interleukin-22 (IL-22), 18/October/2014, 22.45, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance: This study suggests, for the first time, that Argonaute-2, by increasing the expression of IL-22, it may increase insulin sensitivity, restore gut immunity and decrease endotoxaemiaTogether, this study suggests that pharmacological formulations encompassing Argonaute-2 activators” may be used to treat metabolic disorders, including T2DM and cardiac diseases.

Comments are closed.